Syncona Limited is a healthcare investment company based in the United Kingdom. It builds and supports life science businesses, concentrating on areas such as gene therapy and biotechnology, and works closely with founders and management teams to develop treatments for serious diseases. Its portfolio companies operate in the pharmaceutical and medical research fields, serving patients and healthcare systems. Syncona provides capital and long-term backing to these ventures, helping them advance their science from early stages toward clinical use.
Syncona Limited trades under the code SYNC on the London Exchange in UK, with its price quoted in pence sterling (GBX). Our dividend records, which start in 2019, show payments in one calendar year. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Strong price profile
Ranks #1 of 3787 on the London Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendStrong
91/100
Trading above its long-term averages and near its highs.
See the numbers →
Above 200-day average25.2%
From 52-week high-0.3%
MomentumStrong
82/100
Rising faster than most stocks on this exchange.
See the numbers →
3-month return20.2%
6-month return46.3%
12-month, skipping last month15.5%
Stability (higher is calmer)Strong
86/100
Calmer than most: low volatility and shallow drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)20.1%
Worst drawdown, 1 year (smaller is calmer)-15.3%
LiquidityStrong
91/100
Trades actively.
See the numbers →
Avg daily value traded158.43M GBX
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 86.80 – 131.80Daily closes, split-adjusted
Signals
50-day average116.99
200-day average102.68
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)2.87
Technical summary
Daily
Strongly bullish
12 bullish · 2 neutral · 2 bearish
Weekly
Strongly bullish
11 bullish · 0 neutral · 1 bearish
Monthly
Strongly bullish
6 bullish · 1 neutral · 1 bearish
Moving averages (daily)
SMA 10
126.3
Bullish
EMA 10
126.6
Bullish
SMA 20
124.3
Bullish
EMA 20
124.0
Bullish
SMA 50
117.0
Bullish
EMA 50
118.3
Bullish
SMA 100
110.4
Bullish
EMA 100
112.3
Bullish
SMA 200
102.7
Bullish
EMA 200
106.3
Bullish
Oscillators (daily)
RSI (14)
77.09
Bearish
MACD (12, 26)
3.39
Bullish
Momentum (12)
5.41
Bullish
Stochastic %K (14)
68.63
Neutral
Williams %R (14)
-31.37
Neutral
CCI (20)
123.6
Bearish
Pivot points (classic, last session)
S3
124.4
S2
125.8
S1
127.2
Pivot
128.6
R1
130.0
R2
131.4
R3
132.8
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Dividends
Paid, last 12 months
0.00 GBP
Yield on today's price
–
Frequency
None in the last year
Next ex-dividend date
Not announced
Ex-dividend date
Amount per share
0.0230
Ex-dividend dates and amounts from EODHD. Shown as declared, before tax.
Prices are end-of-day closes in GBX. Educational only, not financial advice.
